Yue X - Search Results

1

EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling.

Yue X, Wu F, Wang J, Kim K, Santhamma B, Dileep KV, Zhang KYJ, Viswanadhapalli S, Vadlamudi RK, Ahmed G, Feng Z, Nickisch K, Hu W. Yue X, et al. J Mol Cell Biol. 2020 Jul 3;12(6):477-480. doi: 10.1093/jmcb/mjaa008. J Mol Cell Biol. 2020. PMID: 32221559 Free PMC article. No abstract available.

2

Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy.

Yue X, Zhao Y, Xu Y, Zheng M, Feng Z, Hu W. Yue X, et al. J Mol Biol. 2017 Jun 2;429(11):1595-1606. doi: 10.1016/j.jmb.2017.03.030. Epub 2017 Apr 6. J Mol Biol. 2017. PMID: 28390900 Free PMC article. Review.

3

Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesis.

Yue X, Wang J, Chang CY, Liu J, Yang X, Zhou F, Qiu X, Bhatt V, Guo JY, Su X, Zhang L, Feng Z, Hu W. Yue X, et al. Cell Death Dis. 2022 Apr 19;13(4):370. doi: 10.1038/s41419-022-04820-x. Cell Death Dis. 2022. PMID: 35440095 Free PMC article.

4

LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway.

Li X, Yang Q, Yu H, Wu L, Zhao Y, Zhang C, Yue X, Liu Z, Wu H, Haffty BG, Feng Z, Hu W. Li X, et al. Among authors: yue x. Oncotarget. 2014 Feb 15;5(3):788-801. doi: 10.18632/oncotarget.1772. Oncotarget. 2014. PMID: 24553191 Free PMC article.

5

The regulation of leukemia inhibitory factor.

Yue X, Wu L, Hu W. Yue X, et al. Cancer Cell Microenviron. 2015;2(3):e877. doi: 10.14800/ccm.877. Cancer Cell Microenviron. 2015. PMID: 26807429 Free PMC article.

6

Pontin, a novel interactor of mutant p53 that promotes mutant p53 gain of function.

Zhao Y, Yue X, Hu W. Zhao Y, et al. Among authors: yue x. Mol Cell Oncol. 2015 Jul 29;3(2):e1076587. doi: 10.1080/23723556.2015.1076587. eCollection 2016 Mar. Mol Cell Oncol. 2015. PMID: 27308598 Free PMC article.

7

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis.

Yue X, Zhao Y, Huang G, Li J, Zhu J, Feng Z, Hu W. Yue X, et al. Cell Discov. 2016 Nov 1;2:16039. doi: 10.1038/celldisc.2016.39. eCollection 2016. Cell Discov. 2016. PMID: 27807478 Free PMC article.

8

Gain of function mutant p53 protein activates AKT through the Rac1 signaling to promote tumorigenesis.

Yue X, Wu F, Li Y, Liu J, Boateng M, Mandava K, Zhang C, Feng Z, Gao J, Hu W. Yue X, et al. Cell Cycle. 2020 Jun;19(11):1338-1351. doi: 10.1080/15384101.2020.1749790. Epub 2020 Apr 10. Cell Cycle. 2020. PMID: 32275841 Free PMC article.

9

LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers.

Yu H, Yue X, Zhao Y, Li X, Wu L, Zhang C, Liu Z, Lin K, Xu-Monette ZY, Young KH, Liu J, Shen Z, Feng Z, Hu W. Yu H, et al. Among authors: yue x. Nat Commun. 2014 Oct 17;5:5218. doi: 10.1038/ncomms6218. Nat Commun. 2014. PMID: 25323535 Free PMC article.

10

HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells.

Wu L, Yu H, Zhao Y, Zhang C, Wang J, Yue X, Yang Q, Hu W. Wu L, et al. Among authors: yue x. Oncotarget. 2015 Feb 28;6(6):4406-17. doi: 10.18632/oncotarget.3017. Oncotarget. 2015. PMID: 25726527 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,972 results

Search Page

Filters